Thus, further studies will be needed to elucidate the mechanism underlying the elevated ALT levels observed in patients with NAFLD and mutant ADH1B/ALDH2 alleles. This evidence concerns the gene ADH1B and metabolic dysfunction-associated steatotic liver disease.